Delcath Systems Inc (DCTH) Return on Assets ROA from the third quarter of 2026 to third quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Delcath Systems Inc   (NASDAQ: DCTH)


Delcath Systems Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Delcath Systems Inc 's ROA in the third quarter of 2026?
Delcath Systems Inc achieved a return on average assets (ROA) of 4.96 % in its third quarter of 2026, this is above DCTH's average return on assets of -119.89%.
Delcath Systems Inc assets over the 12 months ending in its third quarter of 2026 are valued at $134 million

ROA has improved compared to 0.42% in the second quarter of 2026, due to net income growth.

However, within the Healthcare sector 204 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the second quarter of 2026 from 2027 to 2444.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Total Assets Change 24.46 % 17.23 % 43.6 % 62.4 % 302.89 %
Y / Y Net Income Change 737.59 % -1.08 % - - -55.47 %
Net Income (TTM) in million 7 1 1 3 1
Return On Assets (TTM) 4.96 % 0.42 % 0.46 % 2.4 % 1.19 %
DCTH's Total Ranking # 2444 # 2027 # 2111 # 1615 # 3757
Total Assets (TTM) in million 154 137 124 123 123
Seq. Total Assets Change 12.03 % 10.56 % 1.01 % -0.51 % 5.52 %
Seq. Net Income Change 160.57 % - - - -69.23 %

DCTH's 5 Years Annual ROA >> Back to DCTH Management Effectiveness >> Compare DCTH ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 67
Sector # 205
Overall # 2437

Return On Assets Statistics
High Average Low
2.86 %
-119.89 %
-438.18 %
  (Mar 31 2019)



  News about Delcath Systems Inc Return on Assets ROA

Delcath Systems Driving Innovation in Liver Cancer Care Amid Strategic Workforce Expansion,

Delcath Systems, Inc.: Advancements in Liver Cancer Treatment and Strategic Employment Inducements Delcath Systems, Inc. (NASDAQ: DCTH), based in Queensbury, New York, is carving a significant niche in the interventional oncology field, particularly focused on therapies targeting primary and metastatic cancers of the liver. Recent announcements from the company highlight its strategic growth initiatives and substantive research developments pertinent to liver-directed cancer treatments.In a recent disclosure, Delcath Systems confirmed the granting of three equity awards as inducements to attract key personnel who commenced employment in August 2024, following approval from the company’s Compensation Committee. The total grants provided the eligible individuals the right to purchase an aggregate of 46,000 shares. This move aligns with Nasdaq Listing Rule 5635(c)(4), emphasizing Delcath s commitment to enhancing its workforce with skilled professionals to further its business s within the oncology sector.



Financial Statements
Delcath Systems Inc 's Assets $ 154 million DCTH's Balance sheet
Delcath Systems Inc 's Income $ 7 million Quarterly DCTH's Income Statement
DCTH's Income by Division See DCTH's Income by Division



Annual Return On Assets (Dec 31 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 62.4 % 96.18 % 119.09 % -45.92 % -3.53 %
Total Assets in million 123 76 39 18 33
Y / Y Net Income Change - - - - -
Net Income in million 3 -26 -48 -37 -26
Annual Return On Assets 2.2 % -34.93 % -123.81 % -207.7 % -78.92 %

DCTH's 5 Years Annual ROA >> Back to DCTH Management Effectiveness >> Compare DCTH ROA to its Competitors



Comment on DCTH's ROA in the fiscal year ending 2025
In the fiscal year 2025 ROA improved to 2.2 % compared to prior year, due to annual net income growth of % to $2.70 million, while value of Delcath Systems Inc 's overall assets grew just by 62.4 % to $122.70 million, compared to $122.70 a year before.


More Return On Assets Ratios
DCTH's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
DCTH's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for DCTH's Competitors
Subscribers only: Roa for Delcath Systems Inc 's Suppliers
Subscribers only: Return On Assets for DCTH's Customers

You may also want to know
DCTH's Roi DCTH's Inventory Turnover Ratio DCTH's Growth Rates DCTH's Dividend Comparisons
DCTH's Profitability Ratios DCTH's Asset Turnover Ratio DCTH's Dividend Growth
DCTH's Roe DCTH's Valuation Ratios DCTH's Financial Strength Ratios DCTH's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector ROA
Illumina Inc   13.43 %
Healthcare Services Group Inc   12.79 %
Kiniksa Pharmaceuticals International Plc  12.64 %
Tenet Healthcare Corp  12.39 %
Hca Healthcare Inc   11.73 %
Carlisle Companies Incorporated  11.72 %
Regeneron Pharmaceuticals Inc   11.50 %
Lantheus Holdings Inc   11.43 %
Msa Safety Inc  11.01 %
Encompass Health Corporation  10.99 %
Inspire Medical Systems inc   10.89 %
Transmedics Group Inc   10.67 %
Bristol myers Squibb Company  10.47 %
Lemaitre Vascular Inc   10.28 %
Bio rad Laboratories Inc   9.88 %
3m Company  9.60 %
Bioventus Inc   9.47 %
Medinotec Inc   8.67 %
Tactile Systems Technology Inc   8.53 %
Penumbra Inc  8.13 %
Johnson and Johnson  8.06 %
Pacific Health Care Organization Inc  7.83 %
Boston Scientific Corporation  7.82 %
Ani Pharmaceuticals Inc  7.77 %
Stryker Corp  7.66 %
Abbvie Inc   7.48 %
Ensign Group Inc  7.00 %
Pediatrix Medical Group Inc   6.99 %
Quest Diagnostics Inc  6.96 %
Davita Inc   6.65 %

Date modified: 2026-11-10T06:10:12+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.